JP2014133711A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014133711A5 JP2014133711A5 JP2013002066A JP2013002066A JP2014133711A5 JP 2014133711 A5 JP2014133711 A5 JP 2014133711A5 JP 2013002066 A JP2013002066 A JP 2013002066A JP 2013002066 A JP2013002066 A JP 2013002066A JP 2014133711 A5 JP2014133711 A5 JP 2014133711A5
- Authority
- JP
- Japan
- Prior art keywords
- extract
- scutellaria baicalensis
- tea
- lafuma
- guava
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 claims 18
- 240000004534 Scutellaria baicalensis Species 0.000 claims 6
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims 6
- 241000185686 Apocynum venetum Species 0.000 claims 3
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 claims 3
- 244000183685 Citrus aurantium Species 0.000 claims 3
- 235000007716 Citrus aurantium Nutrition 0.000 claims 3
- 235000000228 Citrus myrtifolia Nutrition 0.000 claims 3
- 235000016646 Citrus taiwanica Nutrition 0.000 claims 3
- 241000721662 Juniperus Species 0.000 claims 3
- 241000592238 Juniperus communis Species 0.000 claims 3
- 241000508269 Psidium Species 0.000 claims 3
- 244000236580 Psidium pyriferum Species 0.000 claims 3
- 235000013929 Psidium pyriferum Nutrition 0.000 claims 3
- 244000269722 Thea sinensis Species 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 235000020339 pu-erh tea Nutrition 0.000 claims 3
- 235000013616 tea Nutrition 0.000 claims 3
- 102100035905 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 Human genes 0.000 claims 1
- 101000929840 Homo sapiens 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 Proteins 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000004215 skin function Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013002066A JP6204019B2 (ja) | 2013-01-09 | 2013-01-09 | Ｃｇｉ−５８発現促進剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013002066A JP6204019B2 (ja) | 2013-01-09 | 2013-01-09 | Ｃｇｉ−５８発現促進剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014133711A JP2014133711A (ja) | 2014-07-24 |
| JP2014133711A5 true JP2014133711A5 (enExample) | 2016-01-28 |
| JP6204019B2 JP6204019B2 (ja) | 2017-09-27 |
Family
ID=51412283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013002066A Active JP6204019B2 (ja) | 2013-01-09 | 2013-01-09 | Ｃｇｉ−５８発現促進剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6204019B2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7479038B2 (ja) * | 2020-01-20 | 2024-05-08 | 日本メナード化粧品株式会社 | ペプチジルアルギニンデイミナーゼ１発現促進剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH092969A (ja) * | 1995-06-20 | 1997-01-07 | O S Kogyo Kk | アレルギー疾患治療剤 |
| JP2001220312A (ja) * | 2000-02-09 | 2001-08-14 | Ichimaru Pharcos Co Ltd | 植物水蒸気蒸留水含有化粧料組成物 |
| JP2007001914A (ja) * | 2005-06-23 | 2007-01-11 | Nippon Menaade Keshohin Kk | 皮膚バリア機能改善剤 |
| JP2008105985A (ja) * | 2006-10-25 | 2008-05-08 | Nicca Chemical Co Ltd | ヒアルロン酸産生促進剤、皮膚外用剤、浴用剤及び飲食物 |
| JP2009256270A (ja) * | 2008-04-18 | 2009-11-05 | Maruzen Pharmaceut Co Ltd | インスリン様成長因子−１発現促進剤 |
-
2013
- 2013-01-09 JP JP2013002066A patent/JP6204019B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2941263T3 (pl) | Oczyszczony wyciąg wyizolowany z pseudolysimachion rotundum var. subintegrum zawierający liczne składniki czynne, wytwarzanie tego ekstraktu i kompozycja zawierająca ekstrakt jako składnik czynny do zapobiegania lub leczenia zapalenia, alergii i astmy | |
| CA2865972C (en) | Inhalable dry powders | |
| WO2015042449A3 (en) | Novel streptococcus vaccines | |
| WO2015134808A3 (en) | Probiotic formulations and methods for use | |
| EP2471926A3 (en) | Immunostimulatory oligodeoxynucleotides | |
| WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
| WO2012091440A3 (en) | Composition for improvement, treatment and prevention of gastrointestinal motility disorders | |
| WO2015095735A3 (en) | Vaccine compositions and uses thereof | |
| CA2915027A1 (en) | Compositions and methods for administration of vaccines against dengue virus | |
| BR112016012489A2 (pt) | cápsula, método de preparação de uma cápsula contendo flavonoides totais de desmodium styracifolium, e uso da cápsula | |
| WO2016085127A3 (ko) | 펩타이드가 결합된 안정한 아스코르빈산 유도체, 그의 제조방법 및 그를 포함하는 화장료 조성물 | |
| WO2016140933A3 (en) | Immediate release soluble ibuprofen compositions | |
| WO2016030899A8 (en) | Methods of treating amyotrophic lateral scleroses | |
| WO2014102483A3 (fr) | Composition cosmetique ou dermatologique a base d'extraits d'iris et son utilisation | |
| EP3352750A4 (en) | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient | |
| PT3506918T (pt) | Composição que compreende extratos de pólenes e/ou de pistilos, método de preparação e utilizações associadas | |
| WO2010147814A3 (en) | Combinations of herb extracts having synergistic antioxidant effect, and methods relating thereto | |
| WO2011141708A3 (en) | New particles of tetracyclines and protecting agent | |
| JP2014133711A5 (enExample) | ||
| MY190399A (en) | A composition comprising cistanche and ginkgo extracts, the composition useful for improving memory of a subject | |
| WO2014116015A3 (ko) | 자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법 | |
| WO2016197042A8 (en) | Modified or targeted release formulations of linaclotide | |
| WO2015195835A3 (en) | Improved alpha-v beta-8 antibodies | |
| WO2015037019A3 (en) | Modified release pharmaceutical formulations | |
| WO2014166502A3 (en) | Use of immune suppressive domains as medicaments |